- CD011076. doi:10.1002/14651858.CD011076.pub2. PMC 10663978. PMID 25900414.
Killestein J, Ru**** RA,
Polman CH (November 2011). "Oral
treatment for multiple...
- Eyles-Ferris, R; Gompertz, B; Heikkilä, T; Irawati, P; Kennedy, M R;
Killestein, T; Kuncarayakti, H; Levan, A J; Littlefair, S; Makrygianni, L; Marsh...
- PMID 29478727. S2CID 3543215.
Ketelslegers IA,
Modderman PW,
Vennegoor A,
Killestein J,
Hamann D,
Hintzen RQ (December 2011). "Antibodies
against aquaporin-4...
-
Ewald T J; Verwilligen,
Annemiek Y W; Bl****er, Wim K; Thorpe,
Susan J;
Killestein, Joep; Polman,
Chris H; Aalberse, Rob C; Schuurman, Janine; van de Winkel...
- org.
Archived from the
original on 5 July 2022.
Retrieved 7 July 2022.
Killestein, T L; Kelsey, L; Wickens, E; Nuttall, L; Lyman, J; Krawczyk, C; Ackley...
- 1177/1352458513516528. PMID 24468817. S2CID 24226475. Balk LJ,
Tewarie P,
Killestein J,
Polman CH,
Uitdehaag B,
Petzold A (August 2014). "Disease
course heterogeneity...
-
Primary studies during 2010 on neuroimaging, CCSVI, and MS:
Worthington V,
Killestein J,
Eikelenboom MJ,
Teunissen CE,
Barkhof F,
Polman CH, et al. (November...
- and Rheumatism. 52 (9): 2730–9. doi:10.1002/art.21255. PMID 16142756.
Killestein J, Ru**** RA,
Polman CH (November 2011). "Oral
treatment for multiple...
- 66 (2B): 350–3. doi:10.1590/S0004-282X2008000300013. PMID 18641870.
Killestein J,
Kalkers NF,
Polman CH (June 2005). "Glutamate
inhibition in MS: the...
-
Frontiers Beyond the
Decade of the Brain,
Medscape [5] Balk L,
Tewarie P,
Killestein J,
Polman C,
Uitdehaag B,
Petzold A.
Disease course heterogeneity and...
